Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51173#.VFgtyGfHRK0
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51173#.VFgtyGfHRK0
Author(s)
1Faculty of Medicine, Pharmacy and Dental Medicine, “Vasile Goldi?” Western University of Arad, Arad, Romania.
2Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy.
3ENT Division, A.O.R.N. Cardarelli, Naples, Italy.
4ENT Complex Operative Unit, Naples University “Federico II”, Naples, Italy.
2Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy.
3ENT Division, A.O.R.N. Cardarelli, Naples, Italy.
4ENT Complex Operative Unit, Naples University “Federico II”, Naples, Italy.
E-cadherin is present in the epithelial cells and
its aberrant expression is correlated with different kinds of head and
neck squamocellular carcinomas. The purpose of the present study was to
identify the expression particularities of analyzed E-cadherin in
rapport with the localization and the differentiation of various head
and neck squamocellular carcinomas. 18 biopsy fragments obtained by
squamocellular carcinoma patients (larynx, pharynx, hard palate, tongue,
submandibular, lip, gingival sulcus, nasal pyramid, maxillary,
zygomatic) were processed by immunohistochemical staining.
Immunoreactions for E-cadherin in the tumoral cells were examined
according to the score: 0 (0% positive cells of specimen); 1 (<10%
positive cells of specimen); 2 (10% - 30% of specimen); 3 (>30% of
specimen). The immunohistochemical staining indicated the presence of 12
cases of well-differentiated squamocellular carcinoma (7 cases with
score 3, 3 cases with score 2 and 1 case with score 1).
Moderately-differentiated carcinomas were observed in the 3 cases (2
with score 2 and 1 with score 1). The poorly-differentiated
histopathological type was present in 3 cases (all with score 1). Three
types of E-cadherin distribution patterns were found: cytoplasmatic;
cytoplasmatic and membranar; membranar. The presence of maximum score
(value 3) of E-cadherin was found in well-differentiated squamocellular
carcinomas of laryngeal, tongue, lip, nasal pyramid, and zygomatic area
origin. A lower value of the score was present in the less
differentiated histopathological type.
Cite this paper
Vasca, E. , Lile, I. , Luce, A. , Napolitano, D. ,
Ricciardiello, F. , Abate, T. , Caraglia, M. , Duminica, T. and Vasca,
V. (2014) Immunohistochemical Examination of E-Cadherin in the Head
and Neck Squamocellular Carcinomas. International Journal of Otolaryngology and Head & Neck Surgery, 3, 330-336. doi: 10.4236/ijohns.2014.36059.
| [1] | Schipper, H., Frixen, U.H., Behrens, J., Unger, A., Jahnke, K. and Birchmeier, W. (1991) E-Cadherin Expression in Squamous Cell Carcinomas of Head and Neck: Inverse Correlation with Tumor Dedifferentiation and Lymph Node Metastasis. Cancer Research, 51, 6328-6337. |
| [2] | Finkel, T. and Holbrook, N.J.
(2000) Oxidants, Oxidative Stress and the Biology of Ageing. Nature,
408, 239-247. http://dx.doi.org/10.1038/35041687 |
| [3] | Arcasoy, M.O., Jiang, X. and
Haroon, Z.A. (2003) Expression of Erythropoietin Receptor Splice
Variants in Human Cancer. Biochemical and Biophysical Research
Communications, 307, 999-1007. http://dx.doi.org/10.1016/S0006-291X(03)01303-2 |
| [4] | Fong, L. and Engleman, E.G.
(2000) Dendritic Cells in Cancer Immunotherapy. Annual Review of
Immunology, 18, 245-273. http://dx.doi.org/10.1146/annurev.immunol.18.1.245 |
| [5] | Kovács, A.F. (2006) Maximized
Combined Modality Treatment of an Unselected Population of Oral and
Oropharyngeal Cancer Patients. Final Results of a Pilot Study Compared
with a Treatment-Dependent Prognosis Index. Journal of
Cranio-Maxillo-Facial Surgery, 34, 74-84. http://dx.doi.org/10.1016/j.jcms.2005.09.003 |
| [6] | Kovács, A.F., Döbert, N., Gaa,
J., Menzel, C. and Bitter, K. (2004) Positron Emission Tomography in
Combination with Sentinel Node Biopsy Reduces the Rate of Elective Neck
Dissections in the Treatment of Oral and Oropharyngeal Cancer. Journal
of Clinical Oncology, 22, 3973-3980. http://dx.doi.org/10.1200/JCO.2004.01.124 |
| [7] | Buduneli, N., Kardesler, L.,
Isik, H., Willis III, C.S., Hawkins, S.I., Kinane, D.F. and Scott, D.A.
(2006) Effects of Smoking and Gingival Inflammation on Salivary
Antioxidant Capacity. Journal of Clinical Periodontology, 33, 159-164. http://dx.doi.org/10.1111/j.1600-051X.2006.00892.x |
| [8] | Bucur, A., Navarro Vila, C., Lowry, J. and Acero, J. (2009) Compendiu de chirurgie oro-maxilo-faciala. |
| [9] | Balkwill, F. and Mantovani, A.
(2001) Inflammation and Cancer: Back to Virchow? Lancet, 357, 539-545. http://dx.doi.org/10.1016/S0140-6736(00)04046-0 |
| [10] | Tumuluri, V., Thomas, G.A. and
Fraser, I.S. (2002) Analysis of the Ki-67 Antigen at the Invasive Tumour
Front of Human Oral Squamous Cell Carcinoma. Journal of Oral Pathology
& Medicine, 31, 598-604. http://dx.doi.org/10.1034/j.1600-0714.2002.00042.x |
| [11] | Takane, M., Sugano, N., Ezawa,
T., Uchiyama, T. and Ito, K. (2005) A Marker of Oxidative Stress in
Saliva: Association with Periodontally-Involved Teeth of a Hopeless
Prognosis. Journal of Oral Science, 47, 53-57. http://dx.doi.org/10.2334/josnusd.47.53 |
| [12] | Borek, C. (2004) Dietary
Antioxidants and Human Cancer. Integrative Cancer Therapies, 3, 333-341. http://dx.doi.org/10.1177/1534735404270578 |
| [13] | Baselga, J. and Swain, S.M.
(2009) Novel Anticancer Targets: Revisiting ERBB2 and Discovering ERBB3.
Nature Reviews Cancer, 9, 463-475. http://dx.doi.org/10.1038/nrc2656 |
| [14] | Arcasoy, M.O., Amin, K.,
Karayal, A.F., Chou, S.C., Raleigh, J.A., Varia, M.A. and Haroon, Z.A.
(2002) Functional Significance of Erythropoietin Receptor Expression in
Breast Cancer. Laboratory Investigation, 82, 911-918. http://dx.doi.org/10.1097/01.LAB.0000020415.72863.40 |
| [15] | Lalli, A., Tilakaratne, W.M.,
Ariyawardana, A., et al. (2008) An Altered Keratinocyte Phenotype in
Oral Submucous Fibrosis: Correlation of Keratin K17 Expression with
Disease Severity. Journal of Oral Pathology & Medicine, 37, 211-220.
http://dx.doi.org/10.1111/j.1600-0714.2007.00609.x |
| [16] | Rosado, P., Lequerica-Fernández,
P., Fernández, S., Allonca, E., Villallaín, L. and de Vicente, J.C.
(2013) E-Cadherin and β-Catenin Expression in Well-Differentiated and
Moderately-Differentiated Oral Squamous Cell Carcinoma: Relations with
Clinical Variables. British Journal of Oral and Maxillofacial Surgery,
51, 149-156. http://dx.doi.org/10.1016/j.bjoms.2012.03.018 |
| [17] | Wu, H., Lotan, R., Menter, D., Lippman, S.M. and Xu, X.C. (2000) Expression of E-Cadherin Is Associated with Squamous Differentiation in Squamous Cell Carcinomas. Anticancer Research, 20, 1385-1390. eww141104lx |
评论
发表评论